本页面由Tiger Trade Technology Pte. Ltd.提供服务

BioCryst制药

7.59
+0.02000.26%
盘后7.57-0.0206-0.27%19:57 EST
成交量:495.42万
成交额:3,772.47万
市值:15.98亿
市盈率:-167.48
高:7.92
开:7.64
低:7.44
收:7.57
52周最高:11.31
52周最低:6.00
股本:2.11亿
流通股本:2.08亿
量比:1.40
换手率:2.39%
股息:- -
股息率:- -
每股收益(TTM):-0.0453
每股收益(LYR):-0.4300
净资产收益率:587.33%
总资产收益率:10.31%
市净率:-4.12
市盈率(LYR):-17.65

数据加载中...

2025/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/12

重要事件披露

Form 8-K - Current report
2025/12/11

重要事件披露

Form 8-K - Current report
2025/12/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/03

重要事件披露

Form 8-K - Current report
2025/12/03

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/03

重要事件披露

Form 8-K - Current report
2025/10/14

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/10/14

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/10/14

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/10/14

重要事件披露

Form 8-K - Current report
2025/10/14

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/10/01

重要事件披露

Form 8-K - Current report
2025/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities